Mode
Text Size
Log in / Sign up
N/A N=25 Randomized Single-blind Treatment

A Comparison of Visual Function After Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses (IOLs)

Cataract

Enrolled (actual)
25
Serious AEs
6.7%
Results posted
Apr 2017
Primary outcome: Primary: Mean Binocular Defocus VA at Month 3 — 0.78; 0.59; 0.65; 0.45 logMAR

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL Model SN6AD1 (Device); AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL Model SND1TT (Device); Acri.LISA® 366D IOL (Device); Acri.LISA® 466TD Toric IOL (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Alcon Research
Primary completion
Jun 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Binocular Defocus VA at Month 3
0.78; 0.59; 0.65; 0.45; 0.58; 0.29
SECONDARY
Best Corrected Visual Acuity (BCVA) Across a Range of Distances at Month 3
-0.02; -0.05; 0.39; 0.35; 0.33; 0.35
SECONDARY
Uncorrected Visual Acuity Across a Range of Distances at Month 3
0.14; 0.03; 0.37; 0.27; 0.36; 0.33
SECONDARY
Mean Refractive Spherical Equivalent at Month 3
0.1; -0.3
SECONDARY
Mean Radner Reading Speed
90.60; 90.46; 109.7; 113.2
SECONDARY
Patient Reported Outcomes at Month 3
1.78; 1.48; 1.13; 1.19; 1.32; 1.00

Summary

The purpose of this study is to evaluate visual and refractive parameters in a series of subjects bilaterally implanted with presbyopia-correcting intraocular lenses (IOLs) during cataract surgery.

Eligibility Criteria

Inclusion Criteria

  • Sign informed consent;
  • Able to attend postoperative examinations per protocol schedule;
  • Diagnosed with bilateral cataracts;
  • Planned cataract removal by phacoemulsification with implantation of an intraocular lens (IOL);
  • Preoperative astigmatism ≤ 2.5 diopter;
  • Good ocular health, with the exception of cataracts;
  • Free of disease(s)/condition(s) listed in the "Caution" section of the AcrySof IQ and Acri.LISA package inserts;
  • Able to undergo second eye surgery within one month of the first eye surgery;
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Previous corneal surgery;
  • Planned multiple procedures during cataract/IOL implantation surgery;
  • Any ocular disease and/or condition that may compromise study results;
  • Pregnant or planning pregnancy during course of study;
  • History of corneal disease (e.g., herpes simplex, herpes zoster keratitis, etc.)
  • Diabetic retinopathy;
  • Macular degeneration;
  • History of retinal detachment;
  • Other protocol-defined exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01257217). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search